Research groups in MOK

Managed by Professor Vibeke Andersen

Vibeke Andersens’ group is researching to understand the mechanisms of a group of related chronic inflammatory diseases (inflammatory bowel disease, rheumatic conditions, and inflammatory skin conditions), though mostly in inflammatory bowel disease. The group is focusing on predicting treatment response in analyses of inflamed tissue, blood and stool from the patients and on the importance of nutrition and lifestyle for the disease course.

The group is currently engaged in collaboration projects nationally and internationally, among others:

International

• IIBDGC (ibdgenetics.org)
• SYSCID (syscid.eu)
• NORDTREAT
• EPIC-IBD (http://epic.iarc.fr/)

National

• TARCID
• BELIEVE
• IBD-CARE (locally)

Managed by Senior consultant and lecturer Ming Chen

Ming Chens’ group is researching multiresistant bacteria outbreaks and epidemics. Locally, the group is working to understand the relationship between and outbreak of hospital infections, MRSA and C. difficile transmissions using molecular techniques.

The group is currently collaboration nationally and internationally with research groups in USA, France and China to assess H. Pylori and the COVID-19 pandemic.

National collaborations include, among others:

• Meningitis research
• Pathogen genome sequencing
• A cross-sectional study of multiresistant bacteria at Danish emergency wards

Managed by research pharmacist, early lecturer, Lene Juel Kjeldsen

Lene Kjeldsens’ research group was established in 2021 and will study medication treatment in chronic inflammatory diseases. The research group will include a mixture of quantitative and qualitative methods, and include projects locally, nationally and internationally.